We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$580M
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$136M
AUM Growth
-$23M
(-14%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-12.08%
Top 10 Holdings %
Top 10 Hldgs %
63.07%
Holding
41
New
10
Increased
7
Reduced
14
Closed
10
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
1.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.82M |
| 2 |
ATHN
Athenahealth, Inc.
ATHN
|
+$6.11M |
| 3 |
Indaptus Therapeutics
INDP
|
+$5.57M |
| 4 |
Neurogene
NGNE
|
+$5.22M |
| 5 |
Kura Oncology
KURA
|
+$4.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$18.4M |
| 2 |
Sabra Healthcare REIT
SBRA
|
+$9.4M |
| 3 |
AFAM
Almost Family Inc
AFAM
|
+$7.56M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$6.54M |
| 5 |
DexCom
DXCM
|
+$4.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.5% |
| 2 | Industrials | 4.81% |
| 3 | Real Estate | 1.58% |
| 4 | Miscellaneous | 0.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
DELISTED
Kezar Life Sciences
KZR
| $721K | 0.53% |
+4,169
| New | +$727K |
2018 Q2
0 quarters
|
|
|
NVLN
27
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $716K | 0.52% |
194,663
-38,340
| -16% | -$154K |
2017 Q4
2 quarters
|
|
28
DELISTED
Civitas Solutions, Inc.
CIVI
| $568K | 0.42% |
34,649
-129,747
| -79% | -$2.01M |
2018 Q1
1 quarter
|
|
29
Cellectis
CLLS
$111M
| $548K | 0.4% |
+19,388
| New | +$577K |
2018 Q2
0 quarters
|
|
|
AVEO
30
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $337K | 0.25% |
14,907
-89,448
| -86% | -$2.12M |
2017 Q4
2 quarters
|
|
|
AVEO
31
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $158K | 0.12% |
+7,010
| New | +$166K |
2018 Q2
0 quarters
|
|
|
32
DexCom
DXCM
$32.1B
| – | – |
-260,000
| Closed | -$4.82M | – |
|
33
PUT
Inogen
INGN
$168M
| – | – |
-26,800
| Closed | -$3.29M | – |
|
34
uniQure
QURE
$1.48B
| – | – |
-34,100
| Closed | -$801K | – |
|
|
BLCM
35
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – |
-10,605
| Closed | -$696K | – |
|
|
CLVS
36
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-50,000
| Closed | -$2.64M | – |
|
|
CLVS
37
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-46,001
| Closed | -$2.43M | – |
|
|
QTNT
38
DELISTED
Quotient Limited Ordinary Shares
QTNT
| – | – |
-17,055
| Closed | -$3.21M | – |
|
|
AMPE
39
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| – | – |
-371
| Closed | -$378K | – |
|
|
KND
40
DELISTED
Kindred Healthcare
KND
| – | – |
-162,326
| Closed | -$1.49M | – |
|
|
AFAM
41
DELISTED
Almost Family Inc
AFAM
| – | – |
-135,000
| Closed | -$7.56M | – |
|
Similar funds
SC
CCWM
CMA
RIS
MFS
GFI
PWM
CA
Prosight Management's Q2 2018 Portfolio in Review
As of Q2 2018, Prosight Management held 41 positions worth $136M, down 14% from $159M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Prosight Management withdrew a net $16.5M in Q2 2018, closing 10 positions and reducing 14 holdings. Its most notable exit was Almost Family Inc, an estimated $7.56M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 85% a quarter earlier, followed by Industrials and Real Estate.
Against the trend, Prosight Management opened a new position in Athenahealth, Inc. worth $6.55M.
- Prosight Management's largest Q2 2018 buy was Athenahealth, Inc.: 41,193 shares worth $6.55M.
- Prosight Management added most to Cigna in Q2 2018, an estimated $7.82M increase.
- Prosight Management's biggest Q2 2018 reduction was Shire pic, cutting an estimated $18.4M.
- Prosight Management fully exited Almost Family Inc in Q2 2018, selling an estimated $7.56M.
- Prosight Management's ten largest holdings make up 63% of its $136M portfolio in Q2 2018.
- Prosight Management opened 10 new positions and closed 10 in Q2 2018.
- Prosight Management's portfolio value fell 14% quarter-over-quarter to $136M.
Based on Prosight Management's 13F filing for Q2 2018, filed 14 Aug 2018.